微信关注
China
Total item
Cart Subtotal
￥ 0.00 “Tutalthromycin second gen”的搜索结果
-
GSK2795039
Catalog No. A20998 NOX2 inhibitorGSK2795039 is a NADPH oxidase 2 (NOX2) inhibitor with a mean pIC50 of 6 in different cell-free assays. GSK2795039 inhibits reactive oxygen species (ROS) production and NADPH consumption. GSK2795039 reduces apoptosis. 了解更多 -
Seviteronel
Catalog No. A20996 CYP17 lyase inhibitorSeviteronel (VT-464) is a potent CYP17 lyase inhibitor(h-Lyase IC50=69 nM) that demonstrated both exceptional in vitro lyase/hydroxylase selectivity (~10-fold) and oral activity in a hamster model of androgen biosynthesis inhibition. 了解更多 -
Defactinib
Catalog No. A21958 FAK inhibitorDefactinib (VS-6063; PF-04554878) is a novel FAK inhibitor with potential antiangiogenic and antineoplastic activities. 了解更多 -
Etoricoxib D4
Catalog No. A21877 COX-2 inhibitorEtoricoxib D4 (MK-0663 D4) is a deuterium labeled Etoricoxib. Etoricoxib is a non steroidal anti-inflammatory agent, acting as a selective and orally active COX-2 inhibitor, with IC50s of 1.1 μM and 116 μM for COX-2 and COX-1 in human whole blood. 了解更多 -
Rigosertib
Catalog No. A21868 multi-kinase inhibitorRigosertib (ON-01910) is a multi-kinase inhibitor and a selective anti-cancer agent, which induces apoptosis by inhibition the PI3 kinase/Akt pathway, promots the phosphorylation of histone H2AX and induces G2/M arrest in cell cycle. 了解更多 -
(R)-GNE-140
Catalog No. A21863 LDHA inhibitor(R)-GNE-140 is a potent lactate dehydrogenase A (LDHA) inhibitor, with IC50s of 3 nM and 5 nM for LDHA and LDHB, respectively; (R)-GNE-140 is 18-fold more potent than S enantiomer. 了解更多 -
Liarozole dihydrochloride
Catalog No. A21853 CYP450 dependent inhibitorLiarozole dihydrochloride (R75251; R85246) is a cytochrome P450 (CYP450) dependent inhibitor, orally active, it also a potent inhibitor of estrogen (via inhibition of aromatase) and testicular androgen synthesis (inhibition of 17 ,20-lyase). 了解更多 -
Zileuton sodium
Catalog No. A21831 5-lipoxygenase inhibitorZileuton sodium (A 64077 sodium) is a potent and selective inhibitor of 5-lipoxygenase, exhibiting inflammatory activities. 了解更多 -
Rigosertib sodium
Catalog No. A21824 multi-kinase inhibitorRigosertib sodium (ON-01910 sodium) is a multi-kinase inhibitor and a selective anti-cancer agent, which induces apoptosis by inhibition the PI3K/Akt pathway, promotes the phosphorylation of histone H2AX and induces G2/M arrest in cell cycle. 了解更多 -
Taribavirin hydrochloride
Catalog No. A21810 inosine monophosphate dehydrogenase inhibitorTaribavirin hydrochloride is an orally active inosine monophosphate dehydrogenase inhibitor, has activity against a wide range of viruses, especially the hepatitis C virus and influenza virus. 了解更多 -
VP3.15 dihydrobromide
Catalog No. A21789 PDE7/GSK3 inhibitorVP3.15 dihydrobromide is a potent, orally bioavailable and CNS-penetrant dual phosphodiesterase (PDE)7- glycogen synthase kinase (GSK)3 inhibitor, with IC50s of 1.59 μM and 0.88 μM for PDE7 and GSK-3, respectively. 了解更多 -
Glyoxalase I inhibitor free base
Catalog No. A21721 Glyoxalase I (GLO1) inhibitorGlyoxalase I inhibitor (free base) is a potent Glyoxalase I (GLO1) inhibitor, candidate for anticancer agents. 了解更多 -
HS-10296 hydrochloride
Catalog No. A21661 EGFR/T790M inhibitorHS-10296 hydrochloride is an orally available and third-Generation inhibitor of epidermal growth factor receptor (EGFR)-activating mutations and T790M-resistant mutation with limited activity against wild-type EGFR. 了解更多 -
Blasticidin S
Catalog No. A21608 Protein synthesis inhibitorBlasticidin S is a nucleoside antibiotic isolated from Streptomyces griseochromogenes. Blasticidin S is a potent inhibitor of protein synthesis in both prokaryotic and eukaryotic cells. 了解更多 -
Eniluracil
Catalog No. A21548 dihydropyrimidine dehydrogenase inhibitorEniluracil (5-Ethynyluracil), a uracil analogue and a mechanism-based irreversible inhibitor of dihydropyrimidine dehydrogenase (DPD), increases the oral bioavailability of 5-fluorouracil (5-FU) to 100%, facilitating uniform absorption and predictable toxicity. 了解更多 -
Genz-123346
Catalog No. A21536 glucosylceramide synthase inhibitorGenz-123346 is a potent, orally available glucosylceramide synthase inhibitor. 了解更多 -
IACS-010759 Hydrochloride
Catalog No. A21535 Complex I of oxidative phosphorylation inhibitorIACS-10759 Hydrochloride is a potent inhibitor of complex I of oxidative phosphorylation (OXPHOS). 了解更多 -
HO-1-IN-1 hydrochloride
Catalog No. A21527 heme oxygenase 1 (HO-1) inhibitorHO-1-IN-1 hydrochloride (Compound 2) is a heme oxygenase 1 (HO-1) inhibitor with an IC50 of 250 nM. 了解更多 -
Taribavirin
Catalog No. A21525 inosine monophosphate dehydrogenase inhibitorTaribavirin is an orally active inosine monophosphate dehydrogenase inhibitor, has activity against a wide range of viruses, especially the hepatitis C virus and influenza virus. 了解更多 -
Beclabuvir
Catalog No. A21511 HCV NS5B RNA-dependent RNA polymerase inhibitorBeclabuvir is an allosteric inhibitor that binds to thumb site 1 of the hepatitis C virus (HCV) NS5B RNA-dependent RNA polymerase, and inhibits recombinant NS5B proteins from HCV genotypes 1, 3, 4, and 5 with IC50 of < 28 nM. 了解更多 -
Succinyl phosphonate trisodium salt
Catalog No. A21508 KGDHC inhibitorSuccinyl phosphonate trisodium salt is an α-ketoglutarate dehydrogenase (KGDHC) inhibitor, effective inhibits (KGDHC) in muscle, bacterial, brain, and cultured human fibroblasts. 了解更多 -
Docebenone
Catalog No. A21493 5-LO (5-lipoxygenase) inhibitorDocebenone (AA 861) is a potent, selective and orally active 5-LO (5-lipoxygenase) inhibitor. 了解更多 -
6H05 (TFA)
Catalog No. A21377 K-Ras(G12C) inhibitor6H05 TFA is a selective, and allosteric inhibitor of oncogenic mutant K-Ras(G12C). 了解更多 -
Mutant IDH1-IN-2
Catalog No. A21339 IDH inhibitorMutant IDH1-IN-2 is a inhibitor of mutant Isocitrate dehydrogenase (IDH) proteins, with IC50 of in LS-MS biochemical assay, IC50 of 16.6 nM in Fluorescence biochemical assay. 了解更多 -
Valecobulin
Catalog No. A21242 β-tubulin polymerization inhibitorValecobulin (CKD516) is a valine prodrug of (S516) and a vascular disrupting agent (VDA). Valecobulin is a potent β-tubulin polymerization inhibitor with marked antitumor activity against murine and human solid tumors. 了解更多 -
Tin(IV) mesoporphyrin IX dichloride
Catalog No. A21161 HO inhibitorTin(IV) mesoporphyrin IX dichloride (Stannsoporfin) is a heme oxygenase (HO) inhibitor being developed for the prevention of hyperbilirubinemia in infants at risk of developing jaundice, extracted from patent WO2011103196A1. 了解更多 -
Merimepodib
Catalog No. A21139 IMPDH inhibitorMerimepodib is a noncompetitive and oral inhibitor of inosine monophosphate dehydrogenase (IMPDH) with broad spectrum antiviral activities. 了解更多 -
N6-(4-Hydroxybenzyl)adenosine
Catalog No. A21066 platelet aggregation inhibitorN6-(4-Hydroxybenzyl)adenosine is a inhibitor of platelet aggregation induced in vitro by collagen and their activity range was demonstrated (IC50: 6.77-141 μM). 了解更多 -
MIR96-IN-1
Catalog No. A20926 MicroRNA InhibitorMIR96-IN-1 is a selective inhibitor of the biogenesis of microRNA-96. It acts by upregulating a protein target (FOXO1) and inducing apoptosis in cancer cells. 了解更多 -
Clopidogrel thiolactone
Catalog No. A20862 P2Y12 receptor inhibitorClopidogrel thiolactone is a P2Y12 receptor inhibitor, is a potent antiplatelet agent. 了解更多
联系我们
United StatesAdooq Bioscience
Toll Free: (866) 930-6790
Fax: +1-323-606-8156
Email: sales@adooq.com
Not your Region? View all Distributors
FILTER BY:
Filtering:
- 作用机制: Inhibitor (抑制剂) 删除该内容
购物选项
- 分类
-
- Epigenetics (4)
- PI3K / Akt / mTOR (5)
- Protein Tyrosine Kinases (9)
- Angiogenesis (9)
- MAPK (1)
- JAK / Stat (3)
- Cell Cycle (1)
- DNA Damage (5)
- Cell Metabolism (39)
- Autophagy Signaling (1)
- Immunology & Inflammation (15)
- GPCR / G Protein (4)
- TGF-β / Smad (3)
- Neuronal Signaling (15)
- Proteases (6)
- Microbiology (7)
- Stem Cells / Wnt (2)
- Others (4)
- Natural Products (4)
- Ready to Use Solution (13)
- Products On Sale (16)
- 靶点
-
- 2OG oxygenases (2)
- 5-lipoxygenase (1)
- B-Raf (1)
- COX (1)
- COX-1 (1)
- CSF1R (1)
- DNMT (1)
ADOOQ 产品质量保证
We promise all products to perform as described.